L BRI Klearaway

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: L BRI Klearaway
Generic name: SALICYLIC ACID
Manufacturer: L'BRI Health & Beauty
Product type: HUMAN OTC DRUG
SPL set ID: b9aa1c48-b767-47b0-bb98-efb7e860ab36
SPL ID: 55ef88ad-5d72-ca1a-e063-6394a90ad87e
Version: 1
Effective date: 2026-07-06
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:20:05

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		L BRI Klearaway	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		L'BRI Health & Beauty	openfda.manufacturer_name
ndc	package	71238-922-05	openfda.package_ndc
ndc	package	71238-922-30	openfda.package_ndc
ndc	product	71238-922	openfda.product_ndc
ndc11	package	71238092205	derived:openfda.package_ndc
ndc11	package	71238092230	derived:openfda.package_ndc
rxcui		103568	openfda.rxcui
spl id		55ef88ad-5d72-ca1a-e063-6394a90ad87e	id
spl set id		b9aa1c48-b767-47b0-bb98-efb7e860ab36	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once per day. Do not use for prolonged periods without consulting a doctor. Keep out of reach of children. If swallowed, contact physician or poison control center immediately. Store at room temperature.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.